Explore SPDR S&P Emerging Markets ex-China ETF (XCNY) with a $0.0924 price and 2.16% yield.
Start Your NewsReadery Pro FREE TRIAL!
| | |
#investing / Page 7
Invest in SPEM ETF for exposure to emerging markets with a 30-day SEC yield of 2.53%.
Discover the SPDR Portfolio Developed World ex-US ETF (SPDW) with a 30-Day SEC Yield of 2.70%.
Trane Technologies secures spots in prestigious S&P Dow Jones Sustainability Indices, achieves 98th percentile ranking, and leads industry with bold carbon reduction commitments.
Anavex Life Sciences press release (AVXL): Q4 GAAP EPS of -$0.14 beats by $0.02. Cash and cash equivalents of $132.2 million at September 30, 2024, compared to $151.0 million at September 30 ...
Psyence regains Nasdaq listing compliance through strategic moves, maintains strong $5.6M cash position with zero debt as it prepares to launch important clinical trials.
Aveanna Healthcare's management team will showcase at the prestigious JPM Healthcare Conference, offering insights through presentation and investor meetings.
Cytokinetics expands global reach as EMA validates aficamten application for HCM treatment. Drug under review in US, Europe & China, backed by Phase 3 data.
Discover how Gaxos Labs' latest AI upgrade transforms 3D asset creation with enhanced mesh topology control, optimized performance, and streamlined workflows for game developers.
Telomir's Telomir-1 demonstrates copper-binding potential for Wilson's disease treatment, while advancing research in diabetes, cancer, and Alzheimer's. Key trials set for 2026.